Using the Immune System to Fight Lupus dailyRx Rituximab (brand name Rituxan) targets B cells to decrease their number. It has been approved for use in leukemias, lymphomas and autoimmune diseases involving B cells. However, a clinical trial using rituximab in 257 SLE patients failed to show a ... |
